Aminoglycosides are primarily used for which type of infections?

Aminoglycosides are primarily used for serious bacterial infections due to their potent activity against a broad spectrum of Gram-negative bacteria and some Gram-positive bacteria, particularly when the infections are severe or life-threatening. They work by inhibiting protein synthesis in bacteria, leading to bacterial cell death.

These antibiotics are often employed in the treatment of conditions like septicemia, complicated urinary tract infections, and specific types of pneumonia, particularly when caused by resistant organisms. Their effectiveness in serious infections is enhanced when used in combination with other classes of antibiotics, which can help in the treatment of mixed infections or against resistant strains.

Their role in treating serious bacterial infections is crucial, especially in a hospital setting where resistant bacteria are prevalent. This specific application contrasts with the other listed types of infections, as aminoglycosides do not exhibit any activity against viruses, fungi, or parasites.